Harmony Biosciences Holdings, Inc. Announces Poster Presentation Featuring Information From Ongoing Phase 3 Trials Of HBS-301 CI Oct. 01 Deutsche Bank Lifts Price Target on Harmony Biosciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results